التفاصيل البيبلوغرافية
| العنوان: |
Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue-Based Products. |
| المؤلفون: |
Dickson RP; Washtenaw County Tuberculosis Program, Ypsilanti, Michigan.; University of Michigan Medical School, Ann Arbor., Dingell DA; US House of Representatives, Washington, DC. |
| المصدر: |
JAMA [JAMA] 2024 May 28; Vol. 331 (20), pp. 1703-1704. |
| نوع المنشور: |
Case Reports; Journal Article |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: Chicago : American Medical Association, 1960- |
| مواضيع طبية MeSH: |
Government Regulation* , United States Food and Drug Administration*/legislation & jurisprudence , United States Food and Drug Administration*/standards , Bone Transplantation*/adverse effects , Bone Transplantation*/standards , Bone and Bones*/microbiology , Bone and Bones*/surgery , Tuberculosis*/epidemiology , Tuberculosis*/etiology , Tuberculosis*/microbiology , Disease Outbreaks*, Humans ; Cell- and Tissue-Based Therapy/adverse effects ; Cell- and Tissue-Based Therapy/standards ; Tissue Banks/legislation & jurisprudence ; Tissue Banks/standards ; United States/epidemiology ; Mycobacterium tuberculosis/isolation & purification ; Female ; Middle Aged |
| فهرسة مساهمة: |
Local Abstract: [plain-language-summary] This Viewpoint discusses the death of a patient caused by unregulated biological products and efforts to encourage federal government oversight of such products. |
| تواريخ الأحداث: |
Date Created: 20240502 Date Completed: 20240528 Latest Revision: 20240610 |
| رمز التحديث: |
20240611 |
| DOI: |
10.1001/jama.2024.6834 |
| PMID: |
38696201 |
| قاعدة البيانات: |
MEDLINE |
